Reply: To PMID 25212123

Affiliations

¹ Hospital Clinic i Provincial, Hepatic Hemodynamic Laboratory.
² Barcelona Clinic Liver Cancer (BCLC) Group, Liver Unit, Hospital Clinic Barcelona, University of Barcelona, Barcelona, Spain.

Comment

Annalisa Berzigotti et al. Hepatology. 2015 Sep.

. 2015 Sep;62(3):978-9.

doi: 10.1002/hep.27701. Epub 2015 Mar 10.

¹ Hospital Clinic i Provincial, Hepatic Hemodynamic Laboratory.
² Barcelona Clinic Liver Cancer (BCLC) Group, Liver Unit, Hospital Clinic Barcelona, University of Barcelona, Barcelona, Spain.

No abstract available

Comment on

Portal hypertension and the outcome of surgery for hepatocellular carcinoma in compensated cirrhosis: a systematic review and meta-analysis.
Berzigotti A, Reig M, Abraldes JG, Bosch J, Bruix J. Berzigotti A, et al. Hepatology. 2015 Feb;61(2):526-36. doi: 10.1002/hep.27431. Epub 2015 Jan 5. Hepatology. 2015. PMID: 25212123
Portal hypertension and the outcome of surgery for hepatocellular carcinoma in compensated cirrhosis: A systematic review and meta-analysis. More doubts than clarity.
Cucchetti A, Cescon M, Pinna AD. Cucchetti A, et al. Hepatology. 2015 Sep;62(3):976-7. doi: 10.1002/hep.27702. Epub 2015 Feb 13. Hepatology. 2015. PMID: 25598405 No abstract available.
Portal hypertension should not be a contraindication of hepatic resection to treat hepatocellular carcinoma with compensated cirrhosis.
Zhong JH, Li LQ. Zhong JH, et al. Hepatology. 2015 Sep;62(3):977-8. doi: 10.1002/hep.27700. Epub 2015 Feb 24. Hepatology. 2015. PMID: 25643947 No abstract available.
Should surgery be carried out in patients with hepatocellular carcinoma with portal hypertension?
Yang T, Lau WY, Zhang H, Wu M, Shen F. Yang T, et al. Hepatology. 2015 Sep;62(3):976. doi: 10.1002/hep.27703. Epub 2015 Feb 27. Hepatology. 2015. PMID: 25644074 No abstract available.